Sevilgen, G. Et Al. 2022. Effectiveness of Uniportal VATS as the First Line Treatment in Early Stage Empyema: A Single Center Clinical Experience. IRANIAN RED CRESCENT MEDICAL JOURNAL , vol.24, no.4 .

Sevilgen, G., Türüt, H., & Tülüce, K., (2022). Effectiveness of Uniportal VATS as the First Line Treatment in Early Stage Empyema: A Single Center Clinical Experience. IRANIAN RED CRESCENT MEDICAL JOURNAL , vol.24, no.4.

Sevilgen, GÖKÇEN, HASAN TÜRÜT, And KERİM TÜLÜCE. "Effectiveness of Uniportal VATS as the First Line Treatment in Early Stage Empyema: A Single Center Clinical Experience," IRANIAN RED CRESCENT MEDICAL JOURNAL , vol.24, no.4, 2022

Sevilgen, GÖKÇEN Et Al. "Effectiveness of Uniportal VATS as the First Line Treatment in Early Stage Empyema: A Single Center Clinical Experience." IRANIAN RED CRESCENT MEDICAL JOURNAL , vol.24, no.4, 2022

Sevilgen, G. Türüt, H. And Tülüce, K. (2022) . "Effectiveness of Uniportal VATS as the First Line Treatment in Early Stage Empyema: A Single Center Clinical Experience." IRANIAN RED CRESCENT MEDICAL JOURNAL , vol.24, no.4.

@article{article, author={GÖKÇEN SEVİLGEN Et Al. }, title={Effectiveness of Uniportal VATS as the First Line Treatment in Early Stage Empyema: A Single Center Clinical Experience}, journal={IRANIAN RED CRESCENT MEDICAL JOURNAL}, year=2022}